Jan 30, 2024 · Neuralink's clinical trial is called PRIME — for Precise Robotically Implanted Brain-Computer Interface. As the name implies, the process involves using a robot to surgically insert the wires...

Neuralink has one clinical trial available for enrollment in the United States. If you participate in the Patient Registry and we determine that you meet preliminary eligibility for current and/or future clinical trials, we may contact you to inform you of these trials.

Sep 19, 2023 · The PRIME Study (short for Precise Robotically Implanted Brain-Computer Interface) – a groundbreaking investigational medical device trial for our fully-implantable, wireless brain-computer interface (BCI) – aims to evaluate the safety of our implant (N1) and surgical robot (R1) and assess the initial functionality of our BCI for enabling ...

Sep 20, 2023 · Elon Musk’s controversial biotechnology startup Neuralink opened up recruitment for its first human clinical trial Tuesday, according to a company blog.

Apr 12, 2024 · Our first-in-human clinical trial: The PRIME Study. Building the technologies described above has been no small feat. We constructed in-house microfabrication capabilities to rapidly produce various iterations of thin-film arrays that constitute our electrode threads.

Jan 30, 2024 · The U.S. Food and Drug Administration had approved human clinical trials for Neuralink in May 2023. And last September the company announced it was opening enrollment in its first study to...

May 25, 2023 · Elon Musk's Neuralink received U.S. Food and Drug Administration (FDA) clearance for its first-in-human clinical trial, a critical milestone for the brain-implant startup as it faces U.S....

Jan 29, 2024 · In September 2023, Neuralink announced it was opening recruitment for its first human clinical trials of its implant. Patients with quadriplegia and amyotrophic lateral sclerosis (ALS) over the age of 22 are eligible to participate in the ongoing trials.

Jan 16, 2025 · This month, Musk said the next human tests would be using an “upgraded Neuralink device.” The company is also still developing the surgical robot, called R1, that’s used to implant the device.

Jan 17, 2025 · Global trial expansion. What Neuralink has achieved in 20 months since it received US FDA approval to launch its first in-human clinical study is groundbreaking.